NSE filing, NSE: JKPAPER. Summary written from the filing by ALFA Finder's alert engine.
JK Paper Ltd: key numbers
- Share price
- ₹370.10
- Market cap
- ₹6,711 Cr
- Revenue (annual)
- ₹7,076 Cr
- Net profit (annual)
- ₹265.8 Cr
- P/E (TTM)
- 20.7×Sector 45.0×
- Promoter holding
- 52.94%+0.00% QoQ
- FII holding
- 11.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from JK Paper Ltd
All →JK Paper Board Meeting Date
JK Paper has intimated a Board Meeting scheduled for 2 November 2026 to approve unaudited Q1 and H1 FY27 financial results. The trading window remains closed until 5 November 2026.
JK Paper Promoter Buying (Off-Market)
YPL Enterprises' JK Paper stake rose to 7.06% after a Composite Scheme of Arrangement amalgamated four group companies into it. No cash consideration was involved.
- Promoter stake change
- +6.95%
JK Paper Other Announcement
JK Paper Ltd submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
JK Paper Management Change
JK Paper's NRC appointed Gunjan Shah as President (Paper), effective October 12, 2026. The former Bata India MD brings three decades of consumer-sector experience.
JK Paper Legal & Regulatory
JK Paper received a GST demand order of ₹2.54 Crore for alleged excess Input Tax Credit. The company plans to file an appeal against the order.
- Value
- ₹2.54 Cr
JK Paper Credit Rating
JK Paper Ltd announced that CRISIL Ratings has reaffirmed its credit ratings for various bank loan facilities, fixed deposits, NCDs, and commercial papers.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.